2025年全球生命科学行业首席执行官（CEO）展望报告（英文版）.pptxVIP

KPMG2025Global

LifeSciences

CEOOutlook

KPMG.MaketheDifference.

Foreword

Inanageofheighteneddisruption,LifeSciencesCEOsareoptimistic.Manyanticipatestronggrowthoverthecomingyearsonthebackofnewinnovationandtechnology-drivenincreasesinefficiency.AppetiteforMAremainshigh—particularlyfornewtherapeuticareasandcapabilities—

while,atthesametime,significantinvestmentisbeingchanneledtowardsoperationalizingAIandother

digitalizationactivities.

ThisbalancebetweeninnovationandefficiencyiscreatinginterestingopportunitiesforCEOs.Weexpecttosee

continueddivestmentofnon-coreassetsasorganizationssharpentheirmarketfocus,unlockingcapitaltoinvest

intonewinnovationanddrivingtransformationacross

enterprises.TechnologyandAIwillcontinuetoplaya

keyrole,particularlyinthemiddleandbackofficewheresignificantvalueisripeforunlocking.

Akeythemethatemergesacrossthereportistheimportanceofempoweringtheworkforcetoadaptandexperimentinthisrapidlyevolvingsector.CEOsrecognizetheimportanceofenablinghumanswithtechnology,yetinmanycasesarestrugglingtodriveadoptionwhilstretainingtheskillsandcapabilities

requiredtothriveinthefuture.

Inthisreport,KPMG’snetworkofregionalLifeSciencesleadersexploretheresultsofarecentglobalsurveyof

110LifeSciencesCEOsfromaroundtheworld.Supportedbypracticalinsightsandrecommendations,itsintention

istohelpsectorleaders,stakeholdersandinvestors

assessthekeytrends,challengesandopportunitiesfacingorganizationsinthisageofheighteneddisruption.

Throughoutthisreport,“we”,“KPMG”,“us”and“our”referstotheKPMGglobalorganization,toKPMGInternationalLimited(“KPMGInternational”),and/ortooneormoreofthememberfirmsofKPMGInternational,eachofwhichisaseparatelegalentity.

©2026Copyrightownedbyoneo